Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 35-year study

Journal of the Neurological Sciences

Volumn 213, Issue 1-2, 2003, Pages 1-6

  Barnett, M H ^a,b   Williams, D B ^c   Day, S ^a,b   Macaskill, P ^b   McLeod, J G ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Australia; Epidemiology; Incidence; Multiple sclerosis; Prevalence

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0038165888     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(03)00122-9     Document Type: Article

References (22)

1. Hammond S.R., McLeod J.G., Millingen K.S., Stewart-Wynne E.G., English D., Holland J.T.et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain. 111(Pt 1):1988;1-25.
2. Hammond S.R., English D., de Wytt C., Maxwell I.C., Millingen K.S., Stewart-Wynne E.G.et al. The clinical profile of MS in Australia: a comparison between medium- and high-frequency prevalence zones. Neurology. 38:1988;980-986.
3. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group PRISMS. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet. 352:1998;1498-1504.
4. Li D.K., Zhao G.J., Paty D.W. Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results. Neurology. 56:2001;1505-1513.
5. Rose A.S., Ellison G.W., Myers L.W., Tourtellotte W.W. Criteria for the clinical diagnosis of multiple sclerosis. Neurology. 26:1976;20-22.
6. Armitage P., Berry G. Statistical methods in medical research. 1994;Blackwell, Oxford.
7. Dobson A.J., Kuulasmaa K., Eberle E., Scherer Y. Confidence intervals for weighted sums of Poisson parameters. Stat. Med. 10:1991;457-462.
8. Allison R.D., Millar J.H.D. Prevalence and familial incidence of disseminated sclerosis. (A report to the Northern Ireland Hospitals Authority on the results of a three-year survey). Ulster Med. J. 23:1954;5-27.
9. Simmons R.D., Hall C.A., Gleeson P., Everard G., Casse R.F., O'Brien E.D. Prevalence survey of multiple sclerosis in the Australian capital territory. Intern. Med. J. 31:2001;161-167.
10. Compston D.A. Methods of genetic epidemiology in multiple sclerosis. Compston D.A. McAlpine's multiple sclerosis. 1998;45-61 Churchill Livingstone, London.
11. Forbes R.B., Wilson S.V., Swingler R.J. The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist? J. Neurol. 246:1999;1033-1040.
12. Granieri E., Casetta I., Govoni V., Tola M.R., Marchi D., Murgia S.B.et al. The increasing incidence and prevalence of MS in a Sardinian province. Neurology. 55:2000;842-848.
13. Grimaldi L.M., Salemi G., Grimaldi G., Rizzo A., Marziolo R., Lo P.C.et al. High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy. Neurology. 57:2001;1891-1893.
14. Gronlie S.A., Myrvoll E., Hansen G., Gronning M., Mellgren S.I. Multiple sclerosis in North Norway, and first appearance in an indigenous population. J. Neurol. 247:2000;129-1233.
15. McDonnell G.V., Hawkins S.A. An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology. 50:1998;423-428.
16. Pugliatti M., Sotgiu S., Solinas G., Castiglia P., Pirastru M.I., Murgia B.et al. Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurol. Scand. 103:2001;20-26.
17. Sumelahti M.L., Tienari P.J., Wikstrom J., Palo J., Hakama M. Increasing prevalence of multiple sclerosis in Finland. Acta Neurol. Scand. 103:2001;153-158.
18. Wynn D.R., Rodriguez M., O'Fallon W.M., Kurland L.T. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology. 40:1990;780-786.
19. Rice-Oxley M., Williams E.S., Rees J.E. A prevalence survey of multiple sclerosis in Sussex. J. Neurol. Neurosurg. Psychiatry. 58:1995;27-30.
20. Noonan C.W., Kathman S.J., White M.C. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology. 58:2002;136-138.
21. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84:1997;223-243.
22. Onkamo P., Vaananen S., Karvonen M., Tuomilehto J. Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia. 42:1999;1395-1403.